Meeder Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2
| Closed | – | – | 2426 |
|
|
2022
Q2 | $0 | Sell |
2
-24
| -92% | – | ﹤0.01% | 2495 |
|
|
2022
Q1 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 2111 |
|
|
2021
Q4 | – | Sell |
-2,322
| Closed | -$410K | – | 2473 |
|
|
2021
Q3 | $410K | Buy |
+2,322
| New | +$410K | 0.02% | 501 |
|
|
2021
Q2 | – | Sell |
-386
| Closed | -$66K | – | 2715 |
|
|
2021
Q1 | $66K | Buy |
+386
| New | +$66K | ﹤0.01% | 1028 |
|
|
2020
Q4 | – | Sell |
-2,239
| Closed | -$371K | – | 2315 |
|
|
2020
Q3 | $371K | Buy |
2,239
+2,238
| +223,800% | +$371K | 0.02% | 449 |
|
|
2020
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2578 |
|
|
2020
Q1 | – | Sell |
-339
| Closed | -$44K | – | 2594 |
|
|
2019
Q4 | $44K | Buy |
339
+6
| +2% | +$779 | ﹤0.01% | 1061 |
|
|
2019
Q3 | $26K | Sell |
333
-1,167
| -78% | -$91.1K | ﹤0.01% | 1228 |
|
|
2019
Q2 | $154K | Sell |
1,500
-752
| -33% | -$77.2K | 0.01% | 647 |
|
|
2019
Q1 | $166K | Buy |
2,252
+165
| +8% | +$12.2K | 0.01% | 581 |
|
|
2018
Q4 | $89K | Buy |
2,087
+239
| +13% | +$10.2K | 0.01% | 669 |
|
|
2018
Q3 | $88K | Buy |
+1,848
| New | +$88K | 0.01% | 676 |
|
|
2017
Q4 | – | Sell |
-396
| Closed | -$5K | – | 1832 |
|
|
2017
Q3 | $5K | Sell |
396
-247
| -38% | -$3.12K | ﹤0.01% | 1291 |
|
|
2017
Q2 | $2K | Sell |
643
-599
| -48% | -$1.86K | ﹤0.01% | 1445 |
|
|
2017
Q1 | $6K | Sell |
1,242
-492
| -28% | -$2.38K | ﹤0.01% | 1027 |
|
|
2016
Q4 | $8K | Buy |
+1,734
| New | +$8K | ﹤0.01% | 802 |
|